The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Open accessAbstract
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely underappreciated liver condition which is closely associated with obesity and metabolic disease. Despite affecting an estimated 1 in 4 adults globally, NAFLD is largely absent on national and global health agendas. METHODS: We collected data from 102 countries, accounting for 86% of the world population, on NAFLD policies, guidelines, civil society engagement, clinical management, and epidemiologic data. A preparedness index was developed by coding questions into 6 domains (policies, guidelines, civil awareness, epidemiology and data, NAFLD detection, and NAFLD care management) and categorising the responses as high, medium, and low; a multiple correspondence analysis was then applied. RESULTS: The highest scoring countries were India (42.7) and the United Kingdom (40.0), with 32 countries (31%) scoring zero out of 100. For 5 of the domains a minority of countries were categorised as high-level while the majority were categorised as low-level. No country had a national or sub-national strategy for NAFLD and <2% of the different strategies for related conditions included any mention of NAFLD. National NAFLD clinical guidelines were present in only 32 countries. CONCLUSIONS: Although NAFLD is a pressing public health problem, no country was found to be well prepared to address it. There is a pressing need for strategies to address NAFLD at national and global levels. LAY SUMMARY: Around a third of the countries scored a zero on the NAFLD policy preparedness index, with no country scoring over 50/100. Although NAFLD is a pressing public health problem, a comprehensive public health response is lacking in all 102 countries. Policies and strategies to address NAFLD at the national and global levels are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationGlobal burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Self-citationEstes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Self-citationEstes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Self-citationGlobal perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · cited 1×
“Total (102) 32/102 (31) 34/101e(34) 11/33e(33) 34/101e(34) 11/33e(33) 48/94e(51) 4/41e(10) 59/97e(61) 24/59 (41) 57/100e(57) 10/55e(18) 80/98e(82) 2/77e(3) 64/95e(67) 3/60e(5) 85/98e(87) 20/83e(24)”
Self-citationProgression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Self-citationSepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714 · cited 2×
“SubSaharan Africa (15) 0/15 (0) 1/15 (7) 0/1 (0) 1/15 (7) 0/1 (0) 5/13e(38) 0/5 (0) 4/14e(29) 0/4 (0) 4/14e(29) 1/4 (25) 10/14e(71) 0/9e(0) 6/14e(43) 0/5e(0) 10/14e(71) 1/9e(11)”
Self-citationBennett, J. E., Stevens, G. A., Mathers, C. D., Bonita, R., Rehm, J., Kruk, M. E., Riley, L. M., Dain, K., Kengne, A. P., Chalkidou, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31992-5 · Cited by 1,336
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Self-citationAdams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Self-citationEslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 833
Self-citationRisk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757
Self-citationLozano, R., Fullman, N., Abate, D., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32281-5 · Cited by 538
Self-citationAraújo, A. R., Rosso, N., Bedogni, G., Tiribelli, C., & Bellentani, S. (2018) · Liver International · doi:10.1111/liv.13643 · Cited by 401
Management of NAFLD: a stage-based approach
Rinella, M. E., & Sanyal, A. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.3 · Cited by 385
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s004 · Cited by 207
Younossi, Z. M., Tampi, R. P., Racila, A., Qiu, Y., Burns, L., Younossi, I., & Nader, F. (2020) · Diabetes Care · doi:10.2337/dc19-1113 · Cited by 177
Self-citationNon-alcoholic fatty liver disease in lean individuals
Albhaisi, S., Chowdhury, A., & Sanyal, A. J. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.08.002 · Cited by 174
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, J. V., Ekstedt, M., Marchesini, G., Mullen, J., Novak, K., Pericàs, J. M., Roel, E., Romero-Gómez, M., Ratziu, V., Tacke, F., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.027 · Cited by 167
Self-citationPark, S. K., Seo, M. H., Shin, H. C., & Ryoo, J.-H. (2013) · Hepatology · doi:10.1002/hep.26183 · Cited by 158
Arab, J. P., Dirchwolf, M., Álvares‐da‐Silva, M. R., Francisco Barrera, M., Benítez, C., Castellanos, M., Castro‐Narro, G., Chávez-Tapia, N. C., Chiodi, D., Cotrim, H. P., et al. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.09.006 · Cited by 157
Self-citationEkstedt, M., Nasr, P., & Kechagias, S. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0378-2 · Cited by 156
Self-citationDefining comprehensive models of care for NAFLD
Lazarus, J. V., Anstee, Q. M., Hagström, H., Cusi, K. J., Cortez‐Pinto, H., Mark, H. E., Roden, M., Tsochatzis, E. A., Wong, V. W., Younossi, Z. M., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00477-7 · Cited by 152
Self-citationGolabi, P., Otgonsuren, M., Cable, R., Felix, S. C., Koenig, A. B., Sayıner, M., & Younossi, Z. M. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0420-z · Cited by 151
Self-citationCost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
O’Hara, J., Finnegan, A. P., Dhillon, H. S., Ruiz‐Casas, L., Pedra, G., Franks, B., Morgan, G., Hebditch, V., Jönsson, B., Mabhala, M. A., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100142 · Cited by 142
Self-citationHafliðadóttir, S., Jonasson, J. G., Norland, H., Einarsdottir, S., Kleiner, D. E., Lund, S. H., & Bjornsson, E. S. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-166 · Cited by 126
Self-citationYounossi, Z. M., Anstee, Q. M., Wai-Sun Wong, V., Trauner, M., Lawitz, E. J., Harrison, S. A., Camargo, M., Kersey, K., Subramanian, G. M., Myers, R. P., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.003 · Cited by 118
Self-citationLow Awareness of Nonalcoholic Fatty Liver Disease Among Patients at High Metabolic Risk
Wieland, A. C., Mettler, P., McDermott, M. T., Crane, L. A., Cicutto, L. C., & Bambha, K. M. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000075 · Cited by 85
Björkström, K., Stal, P. I., Hultcrantz, R. W., & Hagström, H. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.040 · Cited by 63
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis
McSweeney, L., Breckons, M., Fattakhova, G., Oluboyede, Y., Vale, L. D., Ternent, L., Balp, M., Doward, L. C., Brass, C. A., Beyer, F. R., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100099 · Cited by 58
Self-citationEuropean ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
Lazarus, J. V., Palayew, A., Carrieri, P., Ekstedt, M., Marchesini, G., Novak, K., Ratziu, V., Romero‐Gómez, M., Tacke, F., Zelber‐Sagi, S., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100234 · Cited by 50
Self-citationFouad, Y. M., Lazarus, J. V., Negro, F., Peck‐Radosavljevic, M., Sarin, S. K., Ferenci, P., Esmat, G., Ghazinian, H., Nakajima, A., Silva, M., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16346 · Cited by 45
Self-citationSanyal, A. J. (2018) · BMC Medicine · doi:10.1186/s12916-018-1149-9 · Cited by 34
Cited by
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Self-citationGreenacre, M., Groenen, P. J. F., Hastie, T., D’Enza, A. I., Markos, A., & Tuzhilina, E. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00184-w · Cited by 1,773
Current status and future trends of the global burden of MASLD
Miao, L., Targher, G., Byrne, C. D., Cao, Y.-Y., & Zheng, M.-H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.007 · Cited by 781
Self-citationChanging epidemiology, global trends and implications for outcomes of NAFLD
Wong, V. W.-S., Ekstedt, M., Wong, G. L.-H., & Hagström, H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.036 · Cited by 765
Self-citationMetabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W. S., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki-Järvinen, H., & Loomba, R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 293
Self-citation
Metadata
- Authors
- Lazarus, J. V., Mark, H. E., Villota-Rivas, M., Palayew, A., Carrieri, P., Colombo, M., Ekstedt, M., Esmat, G., George, J., Marchesini, G., Novak, K., Ocama, P., Ratziu, V., Razavi, H., Romero-Gómez, M., Silva, M., Spearman, C. W., Tacke, F., Tsochatzis, E. A., Yilmaz, Y., Younossi, Z. M., Wong, V. W.-S., Zelber-Sagi, S., Cortez-Pinto, H., Anstee, Q. M., Rouabhia, S., Ghazinyan, H., Iskandar, N. J., Trauner, M., Aghayeva, G., Carter, F., Sridharan, K., Al Mahtab, M., Francque, S., Kodjoh, N., Camacho, R. M., Anderson, M., Marques Souza de Oliveira, C. P., Mateva, L., Serme, A. K., Soares Martins, A. A., Swain, M. G., Komas, N. P., Zheng, M.-H., Jaramillo, P. L., Murillo, O. A., Mikolasevic, I., Vounou, E., Brůha, R., Nlombi, C. M., Thiele, M., Perez, M., Suárez M, J. J., Waked, I., Salupere, R., Desalegn, H., Yki-Järvinen, H., Tsertsvadze, T., Sharvadze, L., Butsashvili, M., Awuku, Y. A., Papatheodoridis, G., Hunyady, B., Bjornsson, E. S., Duseja, A., Lesmana, C. R. A., Malekzadeh, R., Norris, S., Koike, K., Nersesov, A. V., Ochwoto, M., Jamal, M., Saparbu, T., Tolmane, I., Sayegh, R., Sheriff, D. S., Valantinas, J., Weber, J., Shawa, I. T., Tan, S.-S., Martínez Vázquez, S. E., Baatarkhuu, O., Lkhagvaa, U., Jadamba, T., Mohammed, T., Sudhamshu, K. C., Coppell, K., Onyekwere, C., Nikolova, D., Vesterhus, M., Al-Naamani, K., Hamid, S., Méndez, J. P., Cabrera Cabrejos, M. C., Flisiak, R., Torres, E. A., Taheri, S., Sung, K.-C., Adela, T., Gheorghe, L., Sanai, F. M., Milovanovic, T., Bee Goh, G. B., Rac, M., Dassanayake, A., Osama, S. B., Elsanousi, M., Dufour, J.-F., Kao, J.-H., Saidi, D., Treeprasertsuk, S., Koek, G., Labidi, A., Skrypnyk, I., AlKhatry, M. S., Sadirova, S., Bakieva, S., & Sinkala, E.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 76
- Issue
- 4
- Pages
- 771-780
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3208021269
- Cited by
- 267
- References
- 40
- FWCI
- 26.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.